Skip to main content
Home
FDA
  • LOG IN
  • Thompson FDA
  • Manage Account
  •  
  • 1.800.677.3789

Main navigation

  • LIBRARY
    • FDA Enforcement Manual
    • Guide to Good Clinical Practice
    • FDA Advertising and Promotion Manual
    • Guide to Medical Device Regulation
    • Guide to U.S. Food Labeling Law
  • MY RESEARCH
  • NEWS
    • All News
    • FDA Intelligence
  • DATABASES
    • FDA Enforcement Database
    • Clinlaw State Database
  • RESOURCES
    • FDA Forms
    • Special Reports
    • Judicial Opinions
    • Interactive Tools
  • AGENCY GUIDANCE
    • Enforcement Guidance
    • Clinical Trials Guidance
    • Advertising and Promotion Guidance
    • Medical Device Guidance
    • Food Labeling Guidance
  • ASK THE EXPERT

Login to the Thompson
FDA Compliance Expert

Enter your FDA username.
Enter the password that accompanies your username.
Forgot password?

Questions? Give us a call! 1-800-677-3789

Advertising & Promotion

  • Jan 15, 2019
    House Oversight Committee Gears Up Hearings on Drug Pricing Practices
  • Jan 15, 2019
    AdvaMed Updates Ethics Code on HCP Interactions
  • Jan 11, 2019
    Senators Introduce Bill To Remove Tax Deduction for DTC Drug Advertising
  • Jan 10, 2019
    Eli Lilly Launches Pricing Website
  • Jan 8, 2019
    Georgia Files Lawsuit Against Opioid Makers
  • Jan 4, 2019
    Advertising Groups Contend DTC Pricing Proposal Will Not Satisfy Constitutional Scrutiny
  • Jan 3, 2019
    TGA Answers Questions on 2019 Ad Code
  • Dec 22, 2018
    Connecticut Files Suit Against Purdue Pharma, 15 Company Officials Over Opioid Marketing
  • Dec 22, 2018
    Judge Allows National Opioid Case To Continue
  • Dec 21, 2018
    Company Discontinues Supplement Claims After NAD Inquiry
  • More

Good Clinical Practice

  • Mar 5, 2019
    Investigator Receives Untitled Letter over Promotion of Investigational Product
  • Mar 1, 2019
    Pa. Senate Considers Bill Allowing Pediatric Use of Investigational Products
  • Mar 1, 2019
    Groups Recommend EU Changes To Improve Clinical Trial Reporting
  • Feb 28, 2019
    R.I. House Considers State Trials Website
  • Feb 28, 2019
    UK HRA Commits To Driving Trial Transparency
  • Feb 27, 2019
    European Group Examines Use of Big Data
  • Feb 25, 2019
    CTTI Releases Final Recommendations for Mobile Trials
  • Feb 25, 2019
    Two Federal Websites Available for Posting Informed Consent Forms
  • Feb 24, 2019
    FDA Again Extends Comment Period for Waiver of Informed Consent for Minimal Risk Research
  • Feb 24, 2019
    EMA Opens Consultation on ATIMP Clinical Trials
  • More

U.S. Food Labeling

  • Sep 10,2015
    N.Y.C. Chain Restaurants Have Until Dec. 1 To Add Salty Food Warning
  • Sep 1,2015
    CFSAN Hits Company Over Unapproved Claims and ‘Misleading’ Name
  • Aug 27,2015
    Advocacy Group Sues USDA Division Over GMO-related Public Records
  • Aug 18,2015
    FDA: Follow Quantification Rules When They Conflict With Sampling
  • Aug 17,2015
    Canada Threatens Tariffs Over Senate Bill Authorizing Use of Voluntary COOL Labels
  • Aug 13,2015
    CFSAN Blasts Importer for Numerous Alleged Labeling Violations
  • Aug 6,2015
    GMA Petitions FDA for Right To Use Low Levels of Trans Fats in Foods
  • Jul 29,2015
    FDA Re-revises Plans for Nutrition Facts Panel, Wants Daily Value Listing for Added Sugars
  • Jul 27,2015
    House Passage of GMO Preemption Bill Garners Strong Response from All Sides
  • Jul 23,2015
    House Passes Bill Preempting States From Adopting GMO Laws
  • More

FDA Regulation & Enforcement

  • May 26, 2022
    Analysis Finds Drug Ad Spending Stagnant Since 2018
  • May 25, 2022
    Court Will Not Bar FDA From Issuing Notice or Press Release About Compounding Pharmacy Inspection
  • May 24, 2022
    FDA Warns Companies About Selling Violative Supplements
  • May 19, 2022
    FDA: Expedited Abbott Consent Decree Designed To Ensure the Safety and Boost the Supply of Infant Formula
  • May 18, 2022
    DOJ: Device Firm Encouraged Use of Its Products on Multiple Patients with Reuse of Single-Use Disposables
  • May 12, 2022
    Revised AdvaMed Code on Interactions with HCPs Becomes Effective June 1
  • May 12, 2022
    House E&C Committee Draft of FDA User Fee Legislation Would Beef Up Agency’s Inspection Authority
  • May 12, 2022
    Draft Guidances Released on NAC as Supplement, How FDA Will Evaluate Non-listed Food Allergens
  • May 5, 2022
    FDA Proposes Order Directing Philips Respironics To Submit Plan for Handling Recalled Devices
  • May 4, 2022
    HHS OIG: Physician-Owned Device Firm Poses Little Risk of Illegal Kickbacks Despite 2013 Fraud Alert
  • More

Medical Devices

  • Jun 20, 2018
    DOJ: Former Theranos Executives Perpetrated Multimillion-Dollar Fraud Schemes Touting Blood Test Devices
  • Jun 20, 2018
    Revised Draft Guidance on Humanitarian Device Exemptions Incorporates Changes Under Cures Act, FDARA
  • Jun 12, 2018
    FDA Updates Guidance on Seeking Feedback on Proposed Device Submissions To Include MDUFA IV Reforms
  • Jun 5, 2018
    FDA Launches ‘Innovation Challenge’ To Spur Development of Devices To Help Deal With Opioid Crisis
  • May 29, 2018
    FDA Calls for Input on Benefits, Risks of Software Excluded from Regulation as Devices by Cures Act
  • May 24, 2018
    FDA Will Not Impose Additional Regulatory Requirements on the Servicing of Medical Devices — for Now
  • May 17, 2018
    FDA Proposes Changes to Regulations Governing Classifications, Assignments of Devices, Combination Products
  • May 9, 2018
    Draft Guidance Explains FDA Policies on Regulating Device Products With Multiple Functions
  • May 1, 2018
    FDA Releases Working Model for Digital Health Software Precertification Program, Calls for Stakeholder Input
  • Apr 19, 2018
    Allergan To Pay $3.5 Million To Settle Device Defect, Other Allegations Brought Under False Claims Act
  • More

THOMPSON FDA

  • Thompson FDA
  • About Us
  • Manage Account
  • Our Parent Company

COMPLIANCE EXPERT

  • News
  • My Research
  • Our Experts
  •  

RESOURCES

  • FDA Forms
  • Special Reports

HELP

  • Customer Support
  •  
  •  
  •  
  •  

CONTACT

  • headquarter Headquarters
  • contact-number 1.800.677.3789
  • Contact Us
  •  

Copyright © Thompson FDA, a division of CBIS. All rights reserved.

  • Terms
  • Privacy

FDA NEWS
YOU CAN USE

Get instant, free access to the latest news and analysis to keep up with the shifting requirements, recommendations, and expectations of the FDA.

Something went wrong. Please try after some time.